CN116322777A - 杂芳基和杂环基化合物 - Google Patents
杂芳基和杂环基化合物 Download PDFInfo
- Publication number
- CN116322777A CN116322777A CN202180068241.8A CN202180068241A CN116322777A CN 116322777 A CN116322777 A CN 116322777A CN 202180068241 A CN202180068241 A CN 202180068241A CN 116322777 A CN116322777 A CN 116322777A
- Authority
- CN
- China
- Prior art keywords
- compound
- alkyl
- ring
- heteroalkyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063060968P | 2020-08-04 | 2020-08-04 | |
| US63/060,968 | 2020-08-04 | ||
| PCT/US2021/044564 WO2022031862A2 (en) | 2020-08-04 | 2021-08-04 | Heteroaryl and heterocyclyl compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116322777A true CN116322777A (zh) | 2023-06-23 |
Family
ID=80120142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180068241.8A Pending CN116322777A (zh) | 2020-08-04 | 2021-08-04 | 杂芳基和杂环基化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230303502A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4192468A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023536633A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230048523A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116322777A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021321433A1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023002132A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3190778A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022031862A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4531879A1 (en) | 2022-05-25 | 2025-04-09 | Flagship Pioneering Innovations VI, LLC | Compositions of secretory and/or catalytic cells and methods using the same |
| JP2025520113A (ja) | 2022-06-03 | 2025-07-01 | フラッグシップ パイオニアリング イノベーションズ シックス,エルエルシー | 組成物及び方法 |
| IL328729A (en) | 2023-12-01 | 2026-07-01 | Sigilon Therapeutics Inc | Methods for producing stem cell-derived islet-like cells, as well as populations and compositions comprising them |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120263670A1 (en) * | 2008-12-31 | 2012-10-18 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| CN106795225A (zh) * | 2014-08-01 | 2017-05-31 | 麻省理工学院 | 用于抗纤维化材料的修饰的藻酸盐以及应用 |
| CN110036008A (zh) * | 2016-10-03 | 2019-07-19 | 西吉隆医疗股份有限公司 | 化合物、装置及其用途 |
| WO2019195055A1 (en) * | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Implantable particles and related methods |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2411197A (en) * | 1996-04-30 | 1997-11-19 | Affymax Technologies N.V. | Methods for the synthesis of fmoc protected amines |
| EP3215519A1 (en) * | 2014-11-06 | 2017-09-13 | Novartis AG | Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase |
| US20180185368A1 (en) * | 2014-11-06 | 2018-07-05 | Lysosomal Therapeutics Inc. | Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders |
| CR20180229A (es) * | 2015-10-29 | 2018-08-24 | Novartis Ag | Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll |
| IL315310A (en) * | 2017-12-26 | 2024-10-01 | Kymera Therapeutics Inc | Irak degraders and uses thereof |
-
2021
- 2021-08-04 CA CA3190778A patent/CA3190778A1/en active Pending
- 2021-08-04 US US18/019,664 patent/US20230303502A1/en active Pending
- 2021-08-04 BR BR112023002132A patent/BR112023002132A2/pt unknown
- 2021-08-04 CN CN202180068241.8A patent/CN116322777A/zh active Pending
- 2021-08-04 AU AU2021321433A patent/AU2021321433A1/en active Pending
- 2021-08-04 WO PCT/US2021/044564 patent/WO2022031862A2/en not_active Ceased
- 2021-08-04 JP JP2023507667A patent/JP2023536633A/ja active Pending
- 2021-08-04 KR KR1020237007667A patent/KR20230048523A/ko active Pending
- 2021-08-04 EP EP21854105.0A patent/EP4192468A4/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120263670A1 (en) * | 2008-12-31 | 2012-10-18 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
| CN106795225A (zh) * | 2014-08-01 | 2017-05-31 | 麻省理工学院 | 用于抗纤维化材料的修饰的藻酸盐以及应用 |
| CN110036008A (zh) * | 2016-10-03 | 2019-07-19 | 西吉隆医疗股份有限公司 | 化合物、装置及其用途 |
| WO2019195055A1 (en) * | 2018-04-04 | 2019-10-10 | Sigilon Therapeutics, Inc. | Implantable particles and related methods |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023536633A (ja) | 2023-08-28 |
| WO2022031862A2 (en) | 2022-02-10 |
| BR112023002132A2 (pt) | 2023-04-11 |
| KR20230048523A (ko) | 2023-04-11 |
| US20230303502A1 (en) | 2023-09-28 |
| EP4192468A4 (en) | 2024-09-11 |
| WO2022031862A3 (en) | 2022-03-24 |
| CA3190778A1 (en) | 2022-02-10 |
| EP4192468A2 (en) | 2023-06-14 |
| AU2021321433A1 (en) | 2023-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536633A (ja) | ヘテロアリール及びヘテロシクリル化合物 | |
| JP2017501218A (ja) | 二環式アルキル化合物、および合成 | |
| CN107108472B (zh) | 半合成方法 | |
| KR20250028345A (ko) | 진핵생물 개시 인자 2b의 조절제를 제조하는 공정 | |
| JP2026508238A (ja) | Kif18aのインドリン阻害剤の固体製剤及び多形形態 | |
| CN112334454B (zh) | 环保的烯烃水合反应 | |
| KR20240148351A (ko) | 브루톤 티로신 키나제 억제제의 합성 | |
| US20250263377A1 (en) | Methods and compositions for terpenoid tricycloalkane synthesis | |
| ES2977277T3 (es) | Procesos para preparar (3R,4R)-1-bencil-n,4-dimetilpiperidin-3-amina o una de sus sales y procesos para preparar tofacitinib mediante el uso de la misma | |
| WO2025076071A2 (en) | Synthesis of ras inhibitors | |
| JP2020525401A (ja) | デゾシン類似体塩酸塩の結晶形及び非晶質 | |
| CN113277959B (zh) | 一种邻位全氟烷基取代叠氮类化合物的合成方法 | |
| JPS62207268A (ja) | 1,3−ジチオラン−2−チオン誘導体の製造方法 | |
| JP2024518543A (ja) | アゲラスタチンa誘導体および関連する方法 | |
| JPS58124719A (ja) | 抗腫瘍剤 | |
| JPH0558977A (ja) | インドールアルカロイド誘導体製造用の新規中間体化合物 | |
| EP3843712A1 (en) | Process for manufacturing pibrentasvir active drug substance | |
| JPS61204189A (ja) | 新規なペナム環を有する化合物の製造法 | |
| Takao et al. | Substrate synthesis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |